A Nestlé DEI boycott begins this week. What Wisconsinites should know about latest spending freeze
The boycott, organized by the same activist group that planned the 24-hour economic spending blackout on Feb. 28, will last through Friday, March 28. A 40-day "fast" of Target is also underway.
The People's Union USA, led by John Schwarz, also organized a week-long boycott of Amazon that ended last Friday. Schwarz cited several reasons for the upcoming boycott, including Nestlé's alleged use of child labor, in a recent Instagram video.
"This is not just another boycott," Schwarz said. "It is a direct hit to one of the most corrupt global corporations there is."
More: DEI explained: What is DEI and why is it so divisive? What you need to know.
Here's what Wisconsin shoppers should know:
The Nestlé boycott is slightly different from past actions. Unlike the Target and Amazon spending freezes, consumers are urged to avoid buying products from the hundreds of brands Nestlé owns, ranging from pet food to bottled water to candies.
An entire list of brands owned by Nestlé can be found on its website.
The Nestlé boycott begins on Friday, March 21 and runs until Friday, March 28.
The faith community's 40-day boycott is in protest of the retailer's decision to reverse DEI initiatives. It began on Wednesday, March 5, and will continue for 40 days to align with Lent, which ends on Thursday, April 17.
Organizers created targetfast.org to offer information on the boycott.
"This is a fast for accountability," the boycott's website said. "A fast for justice. A fast for a future where corporations do not bow to pressure at the expense of marginalized communities."
More: A 40-day boycott of Target begins this week. Here's what Wisconsinites should know about it
The People's Union USA has more consumer boycotts planned in the coming months. Here is the schedule laid out in a flier found on its website:
Nestlé: March 21-28
Walmart: April 7-14 and May 20-26
Second economic blackout: April 18
General Mills: April 21-28
Amazon: May 6-12
Target: June 3-9
McDonald's: June 24-30
Independence Day boycott: July 4
Social media posts — using #LatinoFreezeMovement and #LatinoFreeze — have also encouraged consumers to "hold your money'' amid freezes on DEI initiatives, National Institutes of Health funding and immigration actions.
The National Action Network, founded by Rev. Al Sharpton, also said in a Feb. 25 news release that it will announce an authorized boycott at the NAN Convention in early April.
Lori Comstock and Chad Murphy contributed to this report.
More: UW-Madison under second investigation by Trump administration amid federal DEI crackdown
This article originally appeared on Milwaukee Journal Sentinel: Nestlé DEI boycott to begin Friday. What to know in Wisconsin
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Equitable Holdings price target lowered to $67 from $68 at Morgan Stanley
Morgan Stanley lowered the firm's price target on Equitable Holdings (EQH) to $67 from $68 and keeps an Overweight rating on the shares. Following Q2 results, the firm is updating its price targets for stocks in the Life Insurance segment under its coverage, the analyst tells investors. Nearly half of the life insurers under its coverage beat expectations on a reported basis and most exceeded expectations on a core basis, the firm adds. Morgan Stanley notes the earnings beats were largely driven by selective favorable underwriting, better than expected performance of macro-sensitive segments, or both. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on EQH: Disclaimer & DisclosureReport an Issue Equitable Holdings price target lowered to $63 from $66 at Wells Fargo Equitable Holdings Reports Q2 2025 Financial Results Equitable Holdings' Earnings Call Highlights Growth Amid Challenges Equitable Holdings reports Q2 EPS ex-items $1.41 consensus $1.30 Equitable Holdings Completes Major Reinsurance Transaction Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq mixed as Home Depot leads out big retail earnings
US stocks traded mixed on Tuesday as Home Depot (HD) led out this week's results from retail giants, as Wall Street weighs the odds of interest rate cuts. The Dow Jones Industrial Average (^DJI) edged up 0.1%, while the S&P 500 (^GSPC) fell about 0.2%. The tech-heavy Nasdaq Composite (^IXIC) declined 0.4%, continuing a muted start to the week for the major gauges. A steady march of earnings reports from retail giants began with Home Depot (HD) results before the bell. Its profit slightly fell short of expectations in the second quarter, but sales ticked higher amid signs of an end to the US housing market slump. The home improvement chain's shares slipped after the release, but recovered some ground as investors parsed the results. Target (TGT) will share its earnings on Wednesday, followed by Walmart (WMT) on Thursday. Taken together, the group's results will provide insight into how companies and consumers are faring as Trump's tariffs kick in. Areas of growth or stagnation are also in high focus, as shifts in buying choices can reflect shoppers' financial confidence. Read more: The latest on Trump's tariffs In the tech world, Intel (INTC) stock got a boost after SoftBank said it will take a $2 billion stake in the struggling chipmaker. That news followed shortly after a Bloomberg report that the Trump administration is looking to take a 10% stake in the company. This week, investors are counting down to Friday, when Federal Reserve Chair Jerome Powell will deliver remarks at the Jackson Hole symposium in Wyoming. The event often signals the latest in central bank policymakers' views on interest rates, and Powell's speech could be his last as Fed chair. Clues as to what may come next at the Fed's September policy meeting will be in focus as stubborn inflation and a faltering job market make officials' next move a particularly tricky one. Meanwhile, President Trump continued to press for further Ukraine talks, reportedly asking Russian President Vladimir Putin to meet with Volodymyr Zelensky. European leaders rallied around the Ukrainian president at his meeting with Trump on Monday, but markets hit pause as uncertainty loomed over his country's fate. Stocks mixed at the open US stocks were mixed on Tuesday. The Dow Jones Industrial Average (^DJI) edged up 0.1%, while the S&P 500 (^GSPC) fell about 0.2%. The tech-heavy Nasdaq Composite (^IXIC) declined 0.4%, continuing Wall Street stocks' muted start to the week. Home Depot (HD) led out this week's results from retail giants, with its earnings report Tuesday showing a return to consistent same-store sales growth in the US amid signs that the housing market could begin to recover. In the tech world, Intel (INTC) shares jumped after SoftBank said it's taking a $2 billion stake and the Trump administration reportedly weighed taking its own stake worth up to 10% of the troubled chipmaker. Wall Street is looking ahead to to Fed chair Jerome Powell's highly anticipated speech in Jackson Hole on Friday signaling the central bank's latest views on interest rates, Intel stock jumps 5% as SoftBank takes $2 billion stake in ailing chip company Yahoo Finance's Daniel Howley reports: Read more here. Viking Therapeutics stock plunges on high dropout rate in weight-loss pill trial Viking Therapeutics (VKTX) stock tumbled 35% in premarket trading after a phase 2 trial of its weight-loss pill showed a high patient dropout rate. The GLP-1 obesity treatment showed some promising results: Patients lost 12.2% of body weight after 13 weeks. However, 28% of patients dropped out of the trial before it was completed. Viking's oral obesity drug, VK2735, aims to compete with Eli Lilly's drug, orforglipron, which saw a 12% weight-loss rate after 72 weeks. Eli Lilly shares rose 1.5% in premarket trading. "Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range — but over 72-weeks," Mizuho analyst Jared Holz wrote in a note. "A much longer trial, and [therefore] LLY looks far better head-to-head." S&P affirms US credit rating US stock futures were muted after the S&P reiterated its credit rating for the US. The 10-year Treasury yield (^TNX) and 30-year yield (^TYX) fell by about 2 basis points to 4.32% and 4.92%, respectively. Bloomberg reports: Read more here. A suite of retail data is set to decode the resilient consumer American shoppers have kept the engine of the nation's GDP humming along. But it's worth pinpointing where all that resilience is coming from, as Yahoo Finance's Hamza Shaban lays out in today's Morning Brief. Read more here. Medtronic appoints 2 new board members after Elliott takes a stake Shares of medical device maker Medtronic (MDT) fell 3% premarket after the company announced it would add two new independent directors to its board. Veteran med-tech executives John Groetelaars and Bill Jellison were appointed, the company said. The change comes as activist investor Elliott Investment Management has become one of its largest shareholders. Additionally, the board formed two new committees, helmed by CEO Geoff Martha. The Growth Committee will evaluate M&A opportunities, R&D investments, and potential divestitures. The Operating Committee will focus on margin expansion and operational efficiency. Home Depot slightly misses Wall Street's mark in Q2 earnings, reiterates guidance Home Depot (HD) released its second-quarter earnings on Tuesday. The retailer's stock fell about 2% premarket before recovering. Yahoo Finance's senior reporter Brooke DiPalma looks at the latest from the home improvement retailer and how the US housing slump has impacted its bottom line. Read more here. Wall Street sees stock market rotation charting 'healthiest path' to new highs The stock market's record rally is showing early signs of broadening beyond Big Tech as investors rotate into lagging sectors, but strategists warn its durability hinges on earnings and Fed policy. Yahoo Finance's Allie Canal reports: Read more here. Premarket trending tickers: Palo Alto, Nu holdings and Intel Here's a look at some of the top stocks trending in premarket trading: Palo Alto Networks (PANW) shares rose 5% in premarket trading on Tuesday after the Santa Clara cybersecurity firm forecast fiscal 2026 revenue and profit above analysts' estimates, citing growing demand for its AI powered cybersecurity solutions. Digital banking group Nu holdings (NU) stock rose 2% before the bell after Morgan Stanley (MS) analyst Jorge Kuri reiterated a Buy rating on the company and set a price target of $18.00. Intel (INTC) stock rose premarket more than 6% after Softbank Group (9984.T) announced a $2 billion capital injection into the US chipmaker that is currently in the middle of a turnaround effort. Good morning. Here's what's happening today. Economic data: Housing starts (July); Building permits (July) Earnings: Home Depot (HD), XPeng (XPEV), Medtronic (MDT), Amer Sports (AS), Toll Brothers (TOL), La-Z-Boy (LZB) Here are some of the biggest stories you may have missed overnight and early this morning: Signs of a healthier path to new records emerge for stocks Nvidia is working on an H20-beating AI chip for China Trump tariffs get S&P seal of approval Why stocks are looking ripe for a regime shift Intel gets a $2 billion lifeline from SoftBank Trump pushes Putin-Zelensky meeting after talks with both Home Depot to report earnings as Wall Street eyes US sales growth Why Google just boosted its stake in a bitcoin miner Intel gets one new investor... for now With chatter today that the government is nearing taking a 10% stake in Intel, I guess I shouldn't be shocked that the bruised tech giant is hoping to gain some Street cred on its future product roadmap by tapping SoftBank and Masa for cash. Embattled Intel CEO Lip-Bu Tan also gains a Trump friend in Masa. SoftBank will invest $2 billion in Intel at $23 a share. 'Semiconductors are the foundation of every industry. For more than 50 years, Intel has been a trusted leader in innovation. This strategic investment reflects our belief that advanced semiconductor manufacturing and supply will further expand in the United States, with Intel playing a critical role," SoftBank chair and CEO Masayoshi Son said in a statement. Intel CEO Lip-Bu Tan added, "We are very pleased to deepen our relationship with SoftBank, a company that's at the forefront of so many areas of emerging technology and innovation and shares our commitment to advancing U.S. technology and manufacturing leadership. Masa and I have worked closely together for decades, and I appreciate the confidence he has placed in Intel with this investment.' It's still something to see this unfolding at Intel, which has billions in cash and is by no means in a financial death spiral. Given Masa's close ties to the Trump administration, I suspect the government stake announcement could come next. None of this is a good signal on Intel's turnaround, bottom line. A Trump administration spokesperson didn't return my request for comment. Stocks mixed at the open US stocks were mixed on Tuesday. The Dow Jones Industrial Average (^DJI) edged up 0.1%, while the S&P 500 (^GSPC) fell about 0.2%. The tech-heavy Nasdaq Composite (^IXIC) declined 0.4%, continuing Wall Street stocks' muted start to the week. Home Depot (HD) led out this week's results from retail giants, with its earnings report Tuesday showing a return to consistent same-store sales growth in the US amid signs that the housing market could begin to recover. In the tech world, Intel (INTC) shares jumped after SoftBank said it's taking a $2 billion stake and the Trump administration reportedly weighed taking its own stake worth up to 10% of the troubled chipmaker. Wall Street is looking ahead to to Fed chair Jerome Powell's highly anticipated speech in Jackson Hole on Friday signaling the central bank's latest views on interest rates, US stocks were mixed on Tuesday. The Dow Jones Industrial Average (^DJI) edged up 0.1%, while the S&P 500 (^GSPC) fell about 0.2%. The tech-heavy Nasdaq Composite (^IXIC) declined 0.4%, continuing Wall Street stocks' muted start to the week. Home Depot (HD) led out this week's results from retail giants, with its earnings report Tuesday showing a return to consistent same-store sales growth in the US amid signs that the housing market could begin to recover. In the tech world, Intel (INTC) shares jumped after SoftBank said it's taking a $2 billion stake and the Trump administration reportedly weighed taking its own stake worth up to 10% of the troubled chipmaker. Wall Street is looking ahead to to Fed chair Jerome Powell's highly anticipated speech in Jackson Hole on Friday signaling the central bank's latest views on interest rates, Intel stock jumps 5% as SoftBank takes $2 billion stake in ailing chip company Yahoo Finance's Daniel Howley reports: Read more here. Yahoo Finance's Daniel Howley reports: Read more here. Viking Therapeutics stock plunges on high dropout rate in weight-loss pill trial Viking Therapeutics (VKTX) stock tumbled 35% in premarket trading after a phase 2 trial of its weight-loss pill showed a high patient dropout rate. The GLP-1 obesity treatment showed some promising results: Patients lost 12.2% of body weight after 13 weeks. However, 28% of patients dropped out of the trial before it was completed. Viking's oral obesity drug, VK2735, aims to compete with Eli Lilly's drug, orforglipron, which saw a 12% weight-loss rate after 72 weeks. Eli Lilly shares rose 1.5% in premarket trading. "Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range — but over 72-weeks," Mizuho analyst Jared Holz wrote in a note. "A much longer trial, and [therefore] LLY looks far better head-to-head." Viking Therapeutics (VKTX) stock tumbled 35% in premarket trading after a phase 2 trial of its weight-loss pill showed a high patient dropout rate. The GLP-1 obesity treatment showed some promising results: Patients lost 12.2% of body weight after 13 weeks. However, 28% of patients dropped out of the trial before it was completed. Viking's oral obesity drug, VK2735, aims to compete with Eli Lilly's drug, orforglipron, which saw a 12% weight-loss rate after 72 weeks. Eli Lilly shares rose 1.5% in premarket trading. "Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range — but over 72-weeks," Mizuho analyst Jared Holz wrote in a note. "A much longer trial, and [therefore] LLY looks far better head-to-head." S&P affirms US credit rating US stock futures were muted after the S&P reiterated its credit rating for the US. The 10-year Treasury yield (^TNX) and 30-year yield (^TYX) fell by about 2 basis points to 4.32% and 4.92%, respectively. Bloomberg reports: Read more here. US stock futures were muted after the S&P reiterated its credit rating for the US. The 10-year Treasury yield (^TNX) and 30-year yield (^TYX) fell by about 2 basis points to 4.32% and 4.92%, respectively. Bloomberg reports: Read more here. A suite of retail data is set to decode the resilient consumer American shoppers have kept the engine of the nation's GDP humming along. But it's worth pinpointing where all that resilience is coming from, as Yahoo Finance's Hamza Shaban lays out in today's Morning Brief. Read more here. American shoppers have kept the engine of the nation's GDP humming along. But it's worth pinpointing where all that resilience is coming from, as Yahoo Finance's Hamza Shaban lays out in today's Morning Brief. Read more here. Medtronic appoints 2 new board members after Elliott takes a stake Shares of medical device maker Medtronic (MDT) fell 3% premarket after the company announced it would add two new independent directors to its board. Veteran med-tech executives John Groetelaars and Bill Jellison were appointed, the company said. The change comes as activist investor Elliott Investment Management has become one of its largest shareholders. Additionally, the board formed two new committees, helmed by CEO Geoff Martha. The Growth Committee will evaluate M&A opportunities, R&D investments, and potential divestitures. The Operating Committee will focus on margin expansion and operational efficiency. Shares of medical device maker Medtronic (MDT) fell 3% premarket after the company announced it would add two new independent directors to its board. Veteran med-tech executives John Groetelaars and Bill Jellison were appointed, the company said. The change comes as activist investor Elliott Investment Management has become one of its largest shareholders. Additionally, the board formed two new committees, helmed by CEO Geoff Martha. The Growth Committee will evaluate M&A opportunities, R&D investments, and potential divestitures. The Operating Committee will focus on margin expansion and operational efficiency. Home Depot slightly misses Wall Street's mark in Q2 earnings, reiterates guidance Home Depot (HD) released its second-quarter earnings on Tuesday. The retailer's stock fell about 2% premarket before recovering. Yahoo Finance's senior reporter Brooke DiPalma looks at the latest from the home improvement retailer and how the US housing slump has impacted its bottom line. Read more here. Home Depot (HD) released its second-quarter earnings on Tuesday. The retailer's stock fell about 2% premarket before recovering. Yahoo Finance's senior reporter Brooke DiPalma looks at the latest from the home improvement retailer and how the US housing slump has impacted its bottom line. Read more here. Wall Street sees stock market rotation charting 'healthiest path' to new highs The stock market's record rally is showing early signs of broadening beyond Big Tech as investors rotate into lagging sectors, but strategists warn its durability hinges on earnings and Fed policy. Yahoo Finance's Allie Canal reports: Read more here. The stock market's record rally is showing early signs of broadening beyond Big Tech as investors rotate into lagging sectors, but strategists warn its durability hinges on earnings and Fed policy. Yahoo Finance's Allie Canal reports: Read more here. Premarket trending tickers: Palo Alto, Nu holdings and Intel Here's a look at some of the top stocks trending in premarket trading: Palo Alto Networks (PANW) shares rose 5% in premarket trading on Tuesday after the Santa Clara cybersecurity firm forecast fiscal 2026 revenue and profit above analysts' estimates, citing growing demand for its AI powered cybersecurity solutions. Digital banking group Nu holdings (NU) stock rose 2% before the bell after Morgan Stanley (MS) analyst Jorge Kuri reiterated a Buy rating on the company and set a price target of $18.00. Intel (INTC) stock rose premarket more than 6% after Softbank Group (9984.T) announced a $2 billion capital injection into the US chipmaker that is currently in the middle of a turnaround effort. Here's a look at some of the top stocks trending in premarket trading: Palo Alto Networks (PANW) shares rose 5% in premarket trading on Tuesday after the Santa Clara cybersecurity firm forecast fiscal 2026 revenue and profit above analysts' estimates, citing growing demand for its AI powered cybersecurity solutions. Digital banking group Nu holdings (NU) stock rose 2% before the bell after Morgan Stanley (MS) analyst Jorge Kuri reiterated a Buy rating on the company and set a price target of $18.00. Intel (INTC) stock rose premarket more than 6% after Softbank Group (9984.T) announced a $2 billion capital injection into the US chipmaker that is currently in the middle of a turnaround effort. Good morning. Here's what's happening today. Economic data: Housing starts (July); Building permits (July) Earnings: Home Depot (HD), XPeng (XPEV), Medtronic (MDT), Amer Sports (AS), Toll Brothers (TOL), La-Z-Boy (LZB) Here are some of the biggest stories you may have missed overnight and early this morning: Signs of a healthier path to new records emerge for stocks Nvidia is working on an H20-beating AI chip for China Trump tariffs get S&P seal of approval Why stocks are looking ripe for a regime shift Intel gets a $2 billion lifeline from SoftBank Trump pushes Putin-Zelensky meeting after talks with both Home Depot to report earnings as Wall Street eyes US sales growth Why Google just boosted its stake in a bitcoin miner Economic data: Housing starts (July); Building permits (July) Earnings: Home Depot (HD), XPeng (XPEV), Medtronic (MDT), Amer Sports (AS), Toll Brothers (TOL), La-Z-Boy (LZB) Here are some of the biggest stories you may have missed overnight and early this morning: Signs of a healthier path to new records emerge for stocks Nvidia is working on an H20-beating AI chip for China Trump tariffs get S&P seal of approval Why stocks are looking ripe for a regime shift Intel gets a $2 billion lifeline from SoftBank Trump pushes Putin-Zelensky meeting after talks with both Home Depot to report earnings as Wall Street eyes US sales growth Why Google just boosted its stake in a bitcoin miner Intel gets one new investor... for now With chatter today that the government is nearing taking a 10% stake in Intel, I guess I shouldn't be shocked that the bruised tech giant is hoping to gain some Street cred on its future product roadmap by tapping SoftBank and Masa for cash. Embattled Intel CEO Lip-Bu Tan also gains a Trump friend in Masa. SoftBank will invest $2 billion in Intel at $23 a share. 'Semiconductors are the foundation of every industry. For more than 50 years, Intel has been a trusted leader in innovation. This strategic investment reflects our belief that advanced semiconductor manufacturing and supply will further expand in the United States, with Intel playing a critical role," SoftBank chair and CEO Masayoshi Son said in a statement. Intel CEO Lip-Bu Tan added, "We are very pleased to deepen our relationship with SoftBank, a company that's at the forefront of so many areas of emerging technology and innovation and shares our commitment to advancing U.S. technology and manufacturing leadership. Masa and I have worked closely together for decades, and I appreciate the confidence he has placed in Intel with this investment.' It's still something to see this unfolding at Intel, which has billions in cash and is by no means in a financial death spiral. Given Masa's close ties to the Trump administration, I suspect the government stake announcement could come next. None of this is a good signal on Intel's turnaround, bottom line. A Trump administration spokesperson didn't return my request for comment. With chatter today that the government is nearing taking a 10% stake in Intel, I guess I shouldn't be shocked that the bruised tech giant is hoping to gain some Street cred on its future product roadmap by tapping SoftBank and Masa for cash. Embattled Intel CEO Lip-Bu Tan also gains a Trump friend in Masa. SoftBank will invest $2 billion in Intel at $23 a share. 'Semiconductors are the foundation of every industry. For more than 50 years, Intel has been a trusted leader in innovation. This strategic investment reflects our belief that advanced semiconductor manufacturing and supply will further expand in the United States, with Intel playing a critical role," SoftBank chair and CEO Masayoshi Son said in a statement. Intel CEO Lip-Bu Tan added, "We are very pleased to deepen our relationship with SoftBank, a company that's at the forefront of so many areas of emerging technology and innovation and shares our commitment to advancing U.S. technology and manufacturing leadership. Masa and I have worked closely together for decades, and I appreciate the confidence he has placed in Intel with this investment.' It's still something to see this unfolding at Intel, which has billions in cash and is by no means in a financial death spiral. Given Masa's close ties to the Trump administration, I suspect the government stake announcement could come next. None of this is a good signal on Intel's turnaround, bottom line. A Trump administration spokesperson didn't return my request for comment. Sign in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
"The WNBA don't pay for my bills" - Angel Reese said her WNBA salary is not even enough to pay for her personal expenses
"The WNBA don't pay for my bills" - Angel Reese said her WNBA salary is not even enough to pay for her personal expenses originally appeared on Basketball Network. When she entered the WNBA, Chicago Sky forward Angel Reese was already one of the most popular women's basketball players in the United States. Despite that, the WNBA salary scale meant that she had to accept a maximum contract of $324,383, which is good for four WNBA seasons to play for the Sky. With an average salary of $81,096 per season and a $73,749 actual pay check for her rookie WNBA campaign in 2024, the former LSU star made it clear that long after the likes of WNBA legends Diana Taurasi and Sue Bird played overseason during the offseason to augment their incomes, league salary in the WNBA was still incredibly too low. "I just hope y'all know," Reese said on Instagram Live, "The WNBA don't pay my bills at all. I don't even think it pays one of my bills. Literally. I'm living beyond my means." Her annual rent alone exceeds her WNBA income After she was drafted by the Sky, Reese chose to stay at a loft-style apartment in Chicago's South Loop area. The high-rise abode has stunning views of the city skyline and Lake Michigan. It also has upscale amenities such as a gym, indoor pool, and basketball court, among others. Reese went on to mention that she spends $8,000 per month on rent expenses alone. If we multiply that by 12 months, that's $96,000 per year, which is by itself already more than what she makes per season from her WNBA contract. "That check that I do get here is a bonus," Reese said at the start of her rookie season. "Being able to play for what, four to five months, and get $75,000 on top of the other endorsements that I'm doing, I think it's a plus for me."No need to play overseas However, the thing with Reese is that, regardless of how much money she would make in the WNBA, she would get paid handsomely one way or the other. As one of college basketball's top female stars, Angel had an NIL valuation of $1.8 million before she even entered the WNBA, owing to deals with the likes of Reebok, Topps, Airbnb, Tampax, Hershey's Reese candy, and Beats by Dre. Aside from her endorsements, Reese also played for the 3-on-3 league Unrivaled, which paid players six-figure salaries ranging from $100K to $250K. Although it wasn't revealed how much she made from the league, Angel's Rose Basketball Club won the inaugural title, which earned her an additional $50,000 championship bonus. Although Angel will not make more than $93,636 until at least the 2027 WNBA season, she is surely not worried about paying her $8,000 monthly rent in Chicago or even living beyond her means if she wants to. That's because with the amount of money she makes on the side, Reese earns more than enough to sustain her personal needs. While the WNBA salary continues to be an issue today between the players and the league, top stars like Angel are no longer forced to spend the WNBA offseason playing overseas just to make ends meet, as Taurasi and Bird did during their story was originally reported by Basketball Network on Aug 19, 2025, where it first appeared.
